Ocular implant project receives €1.4 million

Article

BIOSURF, a research project to develop ocular implants, has been awarded a Ocular implant project receives €1.4 million grant by German Minister Dr Schavan.

BIOSURF, a research project to develop ocular implants, has been awarded a Ocular implant project receives €1.4 million grant by German Minister Dr Schavan.

The grant has been issued to alamedics, Offenhäuser & Berger, the Max-Planck Institute for Intelligent Systems and the Laser Institute in order to develop a new generation of ocular implants for glaucoma.

Dr Christian Lingenfelder, general manager of alamedics and coordinator of the project group, explained, "The implants will allow for better control of intraocular pressure. The newly designed surfaces of artificial intraocular lenses, a combination of innovative materials and nanostructures, will allow for significantly better night vision. Additionally, the interaction of implant and body after implantation will be much better controlled."

Dr Schavan commented, "The BIOSURF research group over the next three years wants to explore new biomaterials and to create nanostructures, which allow controlled interaction of the human body with the implants. To better control the function and durability of the implant, the biomimetic structures researched in this project, will support regeneration of the interface between implant and body."

Recent Videos
(Image credit: Ophthalmology Times Europe) AGS 2025: Clemens Strohmaier, PhD, on improving aqueous humour outflow following excimer laser trabeculostomy
Anat Loewenstein, MD, speaks about the 22nd Annual Angiogenesis, Exudation, and Degeneration Meeting in February 2025 and shares her global forecast for AI-driven home OCT
Sarah M. Thomasy, DVM, PhD, DACVO, a veterinary ophthalmologist at UC Davis, talks about how her research at the Glaucoma 360 symposium
I. Paul Singh, MD, an anterior segment and glaucoma specialist, discusses the Glaucoma 360 conference, where he participated in a panel discussion on the use of artificial intelligence (AI) in glaucoma care.
Charles Wykoff, MD, PhD, discusses his Floretina ICOOR presentation topic, retinal non-perfusion in diabetic retinopathy, with David Hutton, editor of Ophthalmology Times
Elizabeth Cohen, MD, discusses the Zoster Eye Disease study at the 2024 AAO meeting
Vikas Chopra at AAO 2024: Advancements in MIGS are transforming patient care
Victoria L Tseng, MD, PhD, professor of ophthalmology and glaucoma specialist, UCLA
© 2025 MJH Life Sciences

All rights reserved.